文献速递创面修复瘢痕与激光

纳米颗粒介导的二氢杨梅素对糖尿病创面的作用:一项体内研究

Effects of Nanoparticle-Mediated Dihydromyricetin to Diabetic Wounds: An In Vivo Study.
PubMed 文献 · J Burn Care Res · 2024-01-01

本研究以聚乳酸-羟基乙酸共聚物纳米颗粒为载体负载二氢杨梅素制备载药纳米颗粒,以200 µL滴加方式局部应用于糖尿病小鼠创面,观察创面愈合与瘢痕形成。结果显示糖尿病小鼠愈合更快、瘢痕形成更不明显,治疗组血糖升高和体重下降也减轻。因此纳米颗粒介导的二氢杨梅素可能成为糖尿病创面的有效治疗。

要点

  • 载二氢杨梅素纳米颗粒以200 µL滴加局部用于糖尿病小鼠创面。
  • 糖尿病小鼠愈合更快、瘢痕形成更不明显。
  • 治疗组小鼠血糖升高和体重下降减轻。

核心结论

  • 纳米颗粒介导的二氢杨梅素可能是糖尿病创面的有效治疗。

研究设计与样本

  • 体内研究:以聚乳酸-羟基乙酸共聚物纳米颗粒为载体负载二氢杨梅素制备载药纳米颗粒,以200 µL滴加方式局部应用于糖尿病小鼠创面,观察创面愈合与瘢痕形成。

主要发现

  • 糖尿病小鼠愈合更快且瘢痕形成更不明显。
  • 治疗组小鼠血糖升高和体重下降也减轻。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic wound is one of the serious complications of diabetes, and the wound is persistent and easily recurring, which seriously endangers the health and life of patients. How to effectively promote the healing of diabetic wounds has been a hot spot and difficult area of clinical research. Some previous studies have shown that dihydromyricetin has the effects of regulating blood glucose, controlling the severity, and inhibiting scarring. In the present study, we used polylactic-co-glycolic acid nanoparticles as a carrier to load dihydromyricetin to make drug-loaded nanoparticles and applied them dropwise (200 µL) to diabetic mice wounds by topical application to observe the healing and scar formation of diabetic wounds. We found that the healing rate of the diabetic mice was faster and the scar formation was less obvious. In addition, the elevated blood glucose level and weight loss of the mice in the treatment group were also reduced. Therefore, nanoparticle-mediated dihydromyricetin may be an effective treatment for diabetic wounds.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Wang ZN, Ma JC, Xi MF, et al. Effects of Nanoparticle-Mediated Dihydromyricetin to Diabetic Wounds: An In Vivo Study. J Burn Care Res. 2024. PMID: 38236154. doi:10.1093/jbcr/irae003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。